The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, experts warned patients were being denied access to personalised cancer care. Cancer… Read More
News round-up for 29 June – 3 July by Bruno Quinney, Content Team at DDW. This week, experts warn patients are being denied access to personalised cancer care. Cancer research is a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer. The… Read More
Researchers have uncovered the genetic basis of multiple primary lung cancers, shedding light on potential therapeutic targets for treatment. A team of researchers, led by Professor Motoshi Suzuki from the Department of Molecular Oncology, Fujita Health University, Japan, along with graduate student Dat Quoc Tran from the university, distinguished… Read More
A genetic difference carried by nearly one in three could increase the risk of Covid-19 and lung disease, a new study shows. Researchers at the University of Edinburgh found the genetic variant alters a newly discovered enzyme found in lung tissue, disrupting the function of a previously unknown protein. This… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the… Read More
News round-up for 8 – 12 June by Bruno Quinney, Content Team at DDW. This week, new research suggests anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for researchers. The top stories: … Read More
Hundreds of UK cancer patients will benefit from a rollout of specialised blood tests, providing improved access to genetic testing and personalised therapies. The Royal Marsden, who are partnering with Guardant Health, will provide circulating tumour DNA (ctDNA) molecular profiling, using the Guardant360 Liquid assay powered by Infinity. These… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a UK group accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere,… Read More
News round-up for 25–29 May by Bruno Quinney, Content Team at DDW. This week, a UK group has accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere, significant findings in colorectal and brain cancer could shape future cancer treatments. The top stories: UK group steps… Read More
A genetic pattern could explain how colorectal cancer develops, new research suggests. Findings from ChristianaCare’s Helen F Graham Cancer Center & Research Institute identified a developmental genetic pattern that helps explain how colorectal cancer develops, why it becomes aggressive and how long patients are likely to survive. The study, published… Read More
Researchers have made a groundbreaking discovery into why some forms of breast cancer are drug resistant. Cancer scientists at City St George’s, University of London found a ‘molecular signature’ drives drug resistance in an aggressive type of breast cancer known as HER2-positive breast cancer. The… Read More
A new precision medicine approach that combines genetic and functional profiling could predict how glioblastoma will respond to therapy. A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma becomes resistant to treatment and introduces a new approach that paves… Read More
Scale Biosciences (Scale Bio) has launched the ‘100 Million Cell Challenge’, which hopes to push the boundaries of single-cell genomics research, in collaboration with Ultima Genomics and NVIDIA. The programme calls on researchers worldwide to submit proposals for large-scale single cell projects, with the goal of… Read More
A study into long Covid has provided the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Despite considerable global research, studies have so far failed to identify the detailed genetic risk factors for long Covid,… Read More
Cancer Research UK, The University of Manchester and Roche have opened a multi-drug, precision medicine trial for people with rare cancers. The trial is set up to recruit both paediatric and adult patients with any rare cancer type and is one of very few precision medicine platform… Read More
Currently, no effective cure or treatment for Huntington’s disease exists. To accelerate Huntington’s disease research and drug discovery, researchers need access to physiologically relevant human disease models that recapitulate patient phenotypes, in combination with more advanced methods to understand the underlying mechanisms of the disease. Download this… Read More
